Lumea
Andy Ivie is the Chief Technology Officer, Software at Lumea since January 2018. He is also the Owner of Silent T, LLC, a consulting company specializing in rapid web development and medical software since January 2013. Prior to these roles, Andy was the Director of Software Research and Development at Leavitt Medical, Inc. from July 2013 to December 2017, Director of Operations at Hansen Security Corporation from April 2010 to January 2013, and a Developer at MultiLing Corporation from September 2009 to April 2010. Andy completed his education at Brigham Young University from 2003 to 2009.
Lumea
Lumea is reshaping the pathology landscape with innovative technology solutions that elevate and enhance the entire pathology ecosystem. Since its founding in 2013, Lumea has pioneered one of the first software platforms of its kind, offering a comprehensive suite of products, including proprietary specimen-handling consumables, a digitally-enabled Laboratory Information System (LIS), and a premier IMS/Viewer. Lumea’s unique approach to digital pathology not only increases cancer detection rates but also delivers a substantial return on investment in a cost-sensitive environment and ultimately sets a higher standard of patient care in cancer diagnostics. With over 1.5 million digital diagnoses, Lumea ranks among the top 5 digital pathology platforms for clinical use in the United States. For further insights into the transformative benefits of Lumea technology, visit lumeadigital.com.